Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 30 | $1,504,923 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Sep 2024 17:46 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Sep 2024 | Sale | 500 | 16.33 | 8,165 | D |
21 Aug 2024 16:28 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 19 Aug 2024 | Sale | 500 | 15 | 7,500 | D |
18 Jul 2024 20:22 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Jul 2024 | Sale | 1,750 | 27.11 | 47,442 | D |
15 Jul 2024 18:13 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 11 Jul 2024 | Sale | 1,996 | 25 | 49,900 | D |
03 Jul 2024 17:11 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 01 Jul 2024 | Sale | 4,248 | 21.3648 | 90,758 | D |
20 Jun 2024 16:59 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 17 Jun 2024 | Sale | 1,750 | 23.7106 | 41,494 | D |
20 May 2024 20:35 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 May 2024 | Sale | 467 | 25.7543 | 12,027 | D |
20 May 2024 20:35 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 May 2024 | Sale | 1,283 | 25.342 | 32,514 | D |
18 Apr 2024 20:48 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Apr 2024 | Sale | 1,750 | 25.74 | 45,045 | D |
03 Apr 2024 19:18 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 01 Apr 2024 | Sale | 8,153 | 31.78 | 259,102 | D |
29 Mar 2024 16:52 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Mar 2024 | Sale | 5,833 | 35.0438 | 204,410 | D |
20 Mar 2024 16:40 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 18 Mar 2024 | Sale | 1,750 | 31.27 | 54,722 | D |
29 Feb 2024 18:01 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 27 Feb 2024 | Sale | 1,909 | 30 | 57,270 | D |
21 Feb 2024 17:41 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 16 Feb 2024 | Sale | 1,750 | 27.67 | 48,422 | D |
12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,996 | 27.5 | 54,890 | D |
12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 2,916 | 27.5 | 80,190 | D |
12 Feb 2024 21:04 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal Officer | 08 Feb 2024 | Sale | 1,332 | 27.5 | 36,630 | D |
12 Jun 2023 18:23 | FMDT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 08 Jun 2023 | Sale | 3,750 | 20.85 | 78,188 | D |
06 Jun 2023 19:23 | FMDT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Jun 2023 | Sale | 2,247 | 18.3103 | 41,143 | D |
25 Apr 2023 18:44 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 21 Apr 2023 | Sale | 3,750 | 20 | 75,000 | D |
03 Mar 2023 18:16 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Mar 2023 | Sale | 2,248 | 19.3 | 43,386 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 375 | 24.35 | 9,131 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 100 | 24.49 | 2,449 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 200 | 23.44 | 4,688 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 2,450 | 22.9305 | 56,180 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 1,000 | 21.775 | 21,775 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 100 | 24.49 | 2,449 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 400 | 23.25 | 9,300 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 975 | 22.7149 | 22,147 | D |
05 Dec 2022 17:33 | FDMT | 4D Molecular Therapeutics Inc | BIZILY SCOTT | Chief Legal and HR Officer | 01 Dec 2022 | Sale | 400 | 21.515 | 8,606 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)